Report Detail
Global Cancer Cell Biopsy Service Market Growth (Status and Outlook) 2022-2028
- RnM4469963 |
- 21 July, 2022 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Service & Software
As the global economy mends, the 2021 growth of Cancer Cell Biopsy Service will have significant change from previous year. According to our (LP Information) latest study, the global Cancer Cell Biopsy Service market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cancer Cell Biopsy Service market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Cancer Cell Biopsy Service market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cancer Cell Biopsy Service market, reaching US$ million by the year 2028. As for the Europe Cancer Cell Biopsy Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Cancer Cell Biopsy Service players cover ANGLE, Fluxion Biosciences, Inivata, and GRAIL, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Cell Biopsy Service market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Incisional Biopsy
Needle Biopsy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
ANGLE
Fluxion Biosciences
Inivata
GRAIL
Guardant Health
Caris
Liquid Biopsy Labs
DermTech
QIAGEN
Lucence
Biocept
CELLSEARCH
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cancer Cell Biopsy Service Market Size 2017-2028
- 2.1.2 Cancer Cell Biopsy Service Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Cancer Cell Biopsy Service Segment by Type
- 2.2.1 Incisional Biopsy
- 2.2.2 Needle Biopsy
- 2.3 Cancer Cell Biopsy Service Market Size by Type
- 2.3.1 Cancer Cell Biopsy Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Cancer Cell Biopsy Service Market Size Market Share by Type (2017-2022)
- 2.4 Cancer Cell Biopsy Service Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.5 Cancer Cell Biopsy Service Market Size by Application
- 2.5.1 Cancer Cell Biopsy Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Cancer Cell Biopsy Service Market Size Market Share by Application (2017-2022)
3 Cancer Cell Biopsy Service Market Size by Player
- 3.1 Cancer Cell Biopsy Service Market Size Market Share by Players
- 3.1.1 Global Cancer Cell Biopsy Service Revenue by Players (2020-2022)
- 3.1.2 Global Cancer Cell Biopsy Service Revenue Market Share by Players (2020-2022)
- 3.2 Global Cancer Cell Biopsy Service Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cancer Cell Biopsy Service by Regions
- 4.1 Cancer Cell Biopsy Service Market Size by Regions (2017-2022)
- 4.2 Americas Cancer Cell Biopsy Service Market Size Growth (2017-2022)
- 4.3 APAC Cancer Cell Biopsy Service Market Size Growth (2017-2022)
- 4.4 Europe Cancer Cell Biopsy Service Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Cancer Cell Biopsy Service Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Cancer Cell Biopsy Service Market Size by Country (2017-2022)
- 5.2 Americas Cancer Cell Biopsy Service Market Size by Type (2017-2022)
- 5.3 Americas Cancer Cell Biopsy Service Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Cancer Cell Biopsy Service Market Size by Region (2017-2022)
- 6.2 APAC Cancer Cell Biopsy Service Market Size by Type (2017-2022)
- 6.3 APAC Cancer Cell Biopsy Service Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Cancer Cell Biopsy Service by Country (2017-2022)
- 7.2 Europe Cancer Cell Biopsy Service Market Size by Type (2017-2022)
- 7.3 Europe Cancer Cell Biopsy Service Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Cancer Cell Biopsy Service by Region (2017-2022)
- 8.2 Middle East & Africa Cancer Cell Biopsy Service Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Cancer Cell Biopsy Service Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Cancer Cell Biopsy Service Market Forecast
- 10.1 Global Cancer Cell Biopsy Service Forecast by Regions (2023-2028)
- 10.1.1 Global Cancer Cell Biopsy Service Forecast by Regions (2023-2028)
- 10.1.2 Americas Cancer Cell Biopsy Service Forecast
- 10.1.3 APAC Cancer Cell Biopsy Service Forecast
- 10.1.4 Europe Cancer Cell Biopsy Service Forecast
- 10.1.5 Middle East & Africa Cancer Cell Biopsy Service Forecast
- 10.2 Americas Cancer Cell Biopsy Service Forecast by Country (2023-2028)
- 10.2.1 United States Cancer Cell Biopsy Service Market Forecast
- 10.2.2 Canada Cancer Cell Biopsy Service Market Forecast
- 10.2.3 Mexico Cancer Cell Biopsy Service Market Forecast
- 10.2.4 Brazil Cancer Cell Biopsy Service Market Forecast
- 10.3 APAC Cancer Cell Biopsy Service Forecast by Region (2023-2028)
- 10.3.1 China Cancer Cell Biopsy Service Market Forecast
- 10.3.2 Japan Cancer Cell Biopsy Service Market Forecast
- 10.3.3 Korea Cancer Cell Biopsy Service Market Forecast
- 10.3.4 Southeast Asia Cancer Cell Biopsy Service Market Forecast
- 10.3.5 India Cancer Cell Biopsy Service Market Forecast
- 10.3.6 Australia Cancer Cell Biopsy Service Market Forecast
- 10.4 Europe Cancer Cell Biopsy Service Forecast by Country (2023-2028)
- 10.4.1 Germany Cancer Cell Biopsy Service Market Forecast
- 10.4.2 France Cancer Cell Biopsy Service Market Forecast
- 10.4.3 UK Cancer Cell Biopsy Service Market Forecast
- 10.4.4 Italy Cancer Cell Biopsy Service Market Forecast
- 10.4.5 Russia Cancer Cell Biopsy Service Market Forecast
- 10.5 Middle East & Africa Cancer Cell Biopsy Service Forecast by Region (2023-2028)
- 10.5.1 Egypt Cancer Cell Biopsy Service Market Forecast
- 10.5.2 South Africa Cancer Cell Biopsy Service Market Forecast
- 10.5.3 Israel Cancer Cell Biopsy Service Market Forecast
- 10.5.4 Turkey Cancer Cell Biopsy Service Market Forecast
- 10.5.5 GCC Countries Cancer Cell Biopsy Service Market Forecast
- 10.6 Global Cancer Cell Biopsy Service Forecast by Type (2023-2028)
- 10.7 Global Cancer Cell Biopsy Service Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 ANGLE
- 11.1.1 ANGLE Company Information
- 11.1.2 ANGLE Cancer Cell Biopsy Service Product Offered
- 11.1.3 ANGLE Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 ANGLE Main Business Overview
- 11.1.5 ANGLE Latest Developments
- 11.2 Fluxion Biosciences
- 11.2.1 Fluxion Biosciences Company Information
- 11.2.2 Fluxion Biosciences Cancer Cell Biopsy Service Product Offered
- 11.2.3 Fluxion Biosciences Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Fluxion Biosciences Main Business Overview
- 11.2.5 Fluxion Biosciences Latest Developments
- 11.3 Inivata
- 11.3.1 Inivata Company Information
- 11.3.2 Inivata Cancer Cell Biopsy Service Product Offered
- 11.3.3 Inivata Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Inivata Main Business Overview
- 11.3.5 Inivata Latest Developments
- 11.4 GRAIL
- 11.4.1 GRAIL Company Information
- 11.4.2 GRAIL Cancer Cell Biopsy Service Product Offered
- 11.4.3 GRAIL Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 GRAIL Main Business Overview
- 11.4.5 GRAIL Latest Developments
- 11.5 Guardant Health
- 11.5.1 Guardant Health Company Information
- 11.5.2 Guardant Health Cancer Cell Biopsy Service Product Offered
- 11.5.3 Guardant Health Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Guardant Health Main Business Overview
- 11.5.5 Guardant Health Latest Developments
- 11.6 Caris
- 11.6.1 Caris Company Information
- 11.6.2 Caris Cancer Cell Biopsy Service Product Offered
- 11.6.3 Caris Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Caris Main Business Overview
- 11.6.5 Caris Latest Developments
- 11.7 Liquid Biopsy Labs
- 11.7.1 Liquid Biopsy Labs Company Information
- 11.7.2 Liquid Biopsy Labs Cancer Cell Biopsy Service Product Offered
- 11.7.3 Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Liquid Biopsy Labs Main Business Overview
- 11.7.5 Liquid Biopsy Labs Latest Developments
- 11.8 DermTech
- 11.8.1 DermTech Company Information
- 11.8.2 DermTech Cancer Cell Biopsy Service Product Offered
- 11.8.3 DermTech Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 DermTech Main Business Overview
- 11.8.5 DermTech Latest Developments
- 11.9 QIAGEN
- 11.9.1 QIAGEN Company Information
- 11.9.2 QIAGEN Cancer Cell Biopsy Service Product Offered
- 11.9.3 QIAGEN Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 QIAGEN Main Business Overview
- 11.9.5 QIAGEN Latest Developments
- 11.10 Lucence
- 11.10.1 Lucence Company Information
- 11.10.2 Lucence Cancer Cell Biopsy Service Product Offered
- 11.10.3 Lucence Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Lucence Main Business Overview
- 11.10.5 Lucence Latest Developments
- 11.11 Biocept
- 11.11.1 Biocept Company Information
- 11.11.2 Biocept Cancer Cell Biopsy Service Product Offered
- 11.11.3 Biocept Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Biocept Main Business Overview
- 11.11.5 Biocept Latest Developments
- 11.12 CELLSEARCH
- 11.12.1 CELLSEARCH Company Information
- 11.12.2 CELLSEARCH Cancer Cell Biopsy Service Product Offered
- 11.12.3 CELLSEARCH Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 CELLSEARCH Main Business Overview
- 11.12.5 CELLSEARCH Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cancer Cell Biopsy Service. Industry analysis & Market Report on Cancer Cell Biopsy Service is a syndicated market report, published as Global Cancer Cell Biopsy Service Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Cancer Cell Biopsy Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
